Board appointment at K-V Pharmaceutical
This article was originally published in Scrip
Executive Summary
K-V Pharmaceutical Company (US) has elected Dr David Sidransky as a new independent member of the board of directors. Dr Sidransky replaces John Sampson, whose resignation from the board was effective upon his appointment. Dr Sidransky is professor of oncology, otolaryngology, cellular and molecular medicine, urology, genetics and pathology at John Hopkins University and Hospital.